Suraksha Diagnostic Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Latest quarter profit grew 40.0% YoY, showing strong momentum
- Operating margins have improved to 32.5% from 22.6%
- Company has consistently been profitable over the last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.79x)
CONS
- Receivables are growing faster than sales - a possible quality concern
- Promoter holding has decreased over last 2 years: -13.9pp
- Equity base is being diluted - shares outstanding up 51.0%
- Stock is trading at 6.4x its book value
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Expensive relative to growth - PEG of 5.2
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8670.00 | 59.66 | 124661.30 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MANIPALHOS | 729.75 | 107.57 | 95989.65 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| MAXHEALTH | 985.00 | 65.80 | 95867.73 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| FORTIS | 910.00 | 65.56 | 68701.19 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 785.80 | 214.94 | 68496.02 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| MEDANTA | 1468.85 | 71.01 | 39493.23 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1859.10 | 46.55 | 37992.72 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 764.15 | 157.10 | 32094.80 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1874.90 | 58.07 | 31469.98 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 514.15 | 109.86 | 16299.90 | 0.00 | 550.20 | 1345.61 | 6140.20 | 1159.73 | 16.14 | 27.75 |
| VIJAYA | 1496.35 | 82.20 | 15412.06 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| SURAKSHA | 331.90 | 48.29 | 1728.56 | 0.15 | 12.84 | 40.00 | 87.65 | 20.74 | 24.92 | 34.73 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 | 52 | 55 | 61 | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 | |
| 39 | 37 | 36 | 40 | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 72 | |
| Operating Profit | 21 | 15 | 19 | 21 | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 15 |
| OPM % | 34.70% | 29.54% | 35.28% | 33.92% | 34.74% | 30.67% | 29.48% | 32.72% | 30.62% | 29.81% | 29.93% | 17.61% |
| 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| Profit before Tax | 11 | 6 | 9 | 11 | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 23.97% | 27.01% | 31.53% | 27.12% | 25.53% | 25.59% | 22.15% | 26.38% | 26.72% | 28.03% | 38.28% | 22.27% |
| Net Profit | 0 | 0 | 0 | 0 | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| 1.58 | 0.87 | 1.22 | 1.49 | 1.94 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 70 | 99 | 157 | 140 | 223 | 190 | 219 | 252 | 325 | |
| 53 | 77 | 123 | 117 | 175 | 146 | 148 | 170 | 238 | |
| Operating Profit | 17 | 22 | 34 | 23 | 48 | 44 | 71 | 82 | 87 |
| OPM % | 24.80% | 22.24% | 21.65% | 16.15% | 21.54% | 23.37% | 32.41% | 32.50% | 26.75% |
| 1 | 1 | 2 | 1 | 2 | 4 | 3 | 4 | 3 | |
| Interest | 1 | 4 | 2 | 2 | 2 | 10 | 10 | 9 | 14 |
| Depreciation | 6 | 9 | 13 | 16 | 15 | 32 | 33 | 35 | 43 |
| Profit before Tax | 12 | 10 | 21 | 6 | 33 | 7 | 31 | 41 | 49 |
| Tax % | 34.69% | 45.05% | 27.61% | -0.96% | 28.45% | 10.12% | 26.47% | 25.18% | 27.85% |
| Net Profit | 8 | 5 | 15 | 6 | 24 | 6 | 23 | 31 | 35 |
| EPS | 0.00 | 0.00 | 178.00 | 75.00 | 278.47 | 1.22 | 342.40 | 6.11 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 10%
- 3 Years:
- 4%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 16%
- 3 Years:
- 10%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 10%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 11%
- Last Year:
- 16%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 7 | 7 | 7 | 7 | 7 | 7 | 7 | 10 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 |
| 41 | 47 | 111 | 118 | 141 | 147 | 171 | 201 | |
| 23 | 33 | 8 | 16 | 19 | 86 | 75 | 74 | |
| Trade Payables | 13 | 10 | 13 | 13 | 14 | 14 | 14 | 14 |
| 20 | 29 | 34 | 17 | 19 | 27 | 33 | 36 | |
| Total Liabilities | 104 | 125 | 173 | 171 | 201 | 281 | 300 | 334 |
| 73 | 91 | 128 | 119 | 119 | 195 | 212 | 223 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 10 |
| 0 | 0 | 5 | 5 | 0 | 0 | 0 | 1 | |
| 2 | 4 | 5 | 4 | 6 | 6 | 7 | 8 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 | |
| Cash & Bank | 12 | 9 | 4 | 4 | 3 | 55 | 55 | 20 |
| 16 | 21 | 30 | 38 | 71 | 22 | 17 | 58 | |
| Total Assets | 104 | 125 | 173 | 171 | 201 | 281 | 300 | 334 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 22 | 16 | 38 | 25 | 47 | 51 | 60 | 63 | |
| Cash from Investing | -42 | -26 | -20 | -28 | -44 | -21 | -35 | -40 |
| Cash from Financing | 17 | 10 | -10 | 3 | 1 | -24 | -25 | -24 |
| -6 | -3 | 1 | -1 | -0 | -1 | 0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||
| EPS (₹) | 109.61 | 79.69 | 220.48 | 93.26 | 344.20 | 94.43 | 342.40 | 6.11 |
| Book Value (₹) | 695.52 | 775.22 | 1712.46 | 1805.72 | 2149.92 | 2236.19 | 2576.52 | 40.52 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 190.66 | 212.72 | 403.02 | 320.97 | 562.91 | 546.90 | 807.60 | 12.73 |
| PROFITABILITY | ||||||||
| Operating Margin % | 26.56% | 23.45% | 22.63% | 17.13% | 22.58% | 25.23% | 32.41% | 32.50% |
| Net Margin % | 10.77% | 5.55% | 9.66% | 4.60% | 10.64% | 3.19% | 10.57% | 12.29% |
| ROE % | 15.76% | 10.84% | 17.73% | 5.30% | 17.40% | 4.01% | 13.93% | 15.93% |
| ROCE % | 16.80% | 16.12% | 20.19% | 6.04% | 22.65% | 9.62% | 22.94% | 24.92% |
| 7.30% | 4.80% | 10.20% | 3.74% | 12.78% | 2.52% | 7.96% | 9.78% | |
| EFFICIENCY | ||||||||
| Debtor Days | 14 | 13 | 12 | 16 | 11 | 12 | 11 | 16 |
| Inventory Days | 11 | 11 | 11 | 13 | 9 | 12 | 11 | 11 |
| Payable Days | 487 | 291 | 196 | 182 | 80 | 186 | 190 | 173 |
| -462 | -266 | -173 | -153 | -60 | -162 | -168 | -146 | |
| FINANCIAL HEALTH | ||||||||
| Debt to Equity (x) | 0.58x | 0.77x | 0.10x | 0.13x | 0.13x | 0.09x | 0.05x | 0.03x |
| Interest Coverage (x) | 8.87x | 3.46x | 11.33x | 4.35x | 16.78x | 1.71x | 4.27x | 5.56x |
| 0.84x | 0.80x | 0.83x | 1.10x | 0.78x | 1.77x | 1.84x | 1.10x | |
| GROWTH | ||||||||
| Revenue Growth % | 0.00% | 41.20% | 58.87% | -11.11% | 59.42% | -14.81% | 15.03% | 15.26% |
| Operating Profit Growth % | 0.00% | 24.65% | 53.35% | -32.70% | 110.05% | -4.78% | 55.14% | 15.24% |
| Net Profit Growth % | 0.00% | -27.30% | 176.66% | -57.70% | 269.06% | -74.46% | 281.31% | 33.95% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 262.58% | -98.22% | |
| VALUATION | ||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 42.19x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 6.36x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.51x | 15.49x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-31 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication published today, i.e. on Monday, 31 August, 2026 with respect to the Notice of the 21st Annual General Meeting of the Company scheduled to be held on Tuesday, 22 September, 2026 and e-voting information.
2026-08-27 - Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter to those Members whose e-mail addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA), i.e. KFin Technologies Limited/Depository Participants (DPs)/Depositories is being dispatched by the Company.
2026-08-27 - Notice of 21st Annual General Meeting to be held on September 22, 2026.
2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript
2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript
2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
News
Recent coverage and analyst commentary for SURAKSHA
Loading news…
AI Stock Analyst
Suraksha Diagnostic Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account

